Kangmei Pharma | 600518

Stock Price
2.03
Daily Change
0 0%
Monthly
-2.40%
Yearly
15.34%
Q3 Forecast
2.01

Peers Price Chg Day Year Date
Cspc Pharmaceutical 11.19 0.36 3.32% 140.13% Sep/05
Avita Medical 1.34 0.01 0.75% -48.46% Sep/05
Sh Fosun Pharma 30.19 0.86 2.93% 34.12% Sep/05
Jiangsu Hengrui 72.47 3.82 5.56% 63.22% Sep/05
Zhangzhou Pientzehuang Pharmaceutical 203.87 0.94 0.46% 0.69% Sep/05
Kangmei Pharma 2.03 0 0% 15.34% Sep/05
WuXi AppTec 107.40 5.46 5.36% 176.80% Sep/05
Tectonic Therapeutic 16.80 -0.47 -2.72% -8.50% Sep/05
Hypermarcas 23.45 0.20 0.86% -17.20% Sep/05
Ionis Pharmaceuticals 61.23 1.88 3.17% 30.58% Sep/05
IQVIA Holdings 187.68 3.60 1.96% -22.83% Sep/05
Genomma Lab Internacional 22.59 0.14 0.62% 14.44% Sep/05
Dianthus Therapeutics 26.50 1.84 7.46% -0.45% Sep/05
Moderna 25.14 0.86 3.54% -65.54% Sep/05
Organon & Co 10.38 0.70 7.23% -49.40% Sep/05
Revvity 86.64 0.94 1.10% -24.90% Sep/05
Viatris 10.50 0.17 1.65% -6.87% Sep/05
Xeris Pharmaceuticals 7.85 -0.04 -0.51% 212.75% Sep/05
Alaunos Therapeutics 2.16 0 0% -10.74% Sep/05

Indexes Price Day Year Date
SHANGHAI 3813 46.64 1.24% 37.84% Sep/05

Kangmei Pharma traded at 2.03 this Friday September 5th. Looking back, over the last four weeks, Kangmei Pharma lost 2.40 percent. Over the last 12 months, its price rose by 15.34 percent. Looking ahead, we forecast Kangmei Pharma to be priced at 2.01 by the end of this quarter and at 1.96 in one year, according to Trading Economics global macro models projections and analysts expectations.

Kangmei Pharmaceutical Co., Ltd is a China-based company, principally engaged in the manufacture and sales of pharmaceutical products. The Company's principal products are Chinese medicines, including American ginseng, notoginseng powder, salvia powder, radix codonopsis pilosulae, maltiflower knotweed, angelica and lonicera flower, among others. The Company is also engaged in the trading of Chinese herbal medicines, medical equipment and healthcare products related businesses. It also engages in the provision of real estate leasing and distribution services, among others. The Company mainly conducts its businesses within domestic markets.